8-12 months after phase 1 completion. Next year
Also don’t really care because after GLP and Phase 1 studies coming up plus Walter Reed the company would be significantly de risked heading into phase 2 and the market cap will be a 100 million dollar market cap like its peers.
Keep posting. Apparently the FDA does not recognise the phase 1 studies completed in Australia lol you and Hawk70 should hold hands because AGN submitted its data in a similar fashion.
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-116
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $61.32M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.0¢ | $171.8K | 604.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 61068 | 3 |
View Market Depth
| Last trade - 12.11pm 07/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |